137 related articles for article (PubMed ID: 24965159)
1. Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
Beyeler S; Joly S; Fries M; Obermair FJ; Burn F; Mehmood R; Tabatabai G; Raineteau O
Stem Cells; 2014 Oct; 32(10):2583-95. PubMed ID: 24965159
[TBL] [Abstract][Full Text] [Related]
2. System analysis identifies distinct and common functional networks governed by transcription factor ASCL1, in glioma and small cell lung cancer.
Donakonda S; Sinha S; Dighe SN; Rao MRS
Mol Biosyst; 2017 Jul; 13(8):1481-1494. PubMed ID: 28742165
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
Sharma P; Chinaranagari S; Chaudhary J
Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
[TBL] [Abstract][Full Text] [Related]
4. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation.
Samanta J; Kessler JA
Development; 2004 Sep; 131(17):4131-42. PubMed ID: 15280210
[TBL] [Abstract][Full Text] [Related]
5. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
6. HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation.
Haapa-Paananen S; Kiviluoto S; Waltari M; Puputti M; Mpindi JP; Kohonen P; Tynninen O; Haapasalo H; Joensuu H; Perälä M; Kallioniemi O
Oncogene; 2012 Mar; 31(10):1299-310. PubMed ID: 21785461
[TBL] [Abstract][Full Text] [Related]
7. Targeting SIM2-s decreases glioma cell invasion through mesenchymal--epithelial transition.
Su Y; Wang J; Zhang X; Shen J; Deng L; Liu Q; Li G
J Cell Biochem; 2014 Nov; 115(11):1900-7. PubMed ID: 24909296
[TBL] [Abstract][Full Text] [Related]
8. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.
Kim S; Lahmy R; Riha C; Yang C; Jakubison BL; van Niekerk J; Staub C; Wu Y; Gates K; Dong DS; Konieczny SF; Itkin-Ansari P
Pancreas; 2015 Jul; 44(5):718-27. PubMed ID: 25894862
[TBL] [Abstract][Full Text] [Related]
9. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
[TBL] [Abstract][Full Text] [Related]
10. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
11. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.
Lu F; Chen Y; Zhao C; Wang H; He D; Xu L; Wang J; He X; Deng Y; Lu EE; Liu X; Verma R; Bu H; Drissi R; Fouladi M; Stemmer-Rachamimov AO; Burns D; Xin M; Rubin JB; Bahassi EM; Canoll P; Holland EC; Lu QR
Cancer Cell; 2016 May; 29(5):669-683. PubMed ID: 27165742
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor lactacystin exerts its therapeutic effects on glioma via apoptosis: an in vitro and in vivo study.
Wang H; Zhang S; Zhong J; Zhang J; Luo Y; Pengfei G
J Int Med Res; 2013 Feb; 41(1):72-81. PubMed ID: 23569132
[TBL] [Abstract][Full Text] [Related]
13. bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis.
Hsu SH; Hsieh-Li HM; Huang HY; Huang PH; Li H
Cancer Res; 2005 May; 65(10):4041-50. PubMed ID: 15899793
[TBL] [Abstract][Full Text] [Related]
14. Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.
Peng R; Jiang B; Ma J; Ma Z; Wan X; Liu H; Chen Z; Cheng Q; Chen R
Oncol Rep; 2013 Nov; 30(5):2195-202. PubMed ID: 24008630
[TBL] [Abstract][Full Text] [Related]
15. A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation.
Tabu K; Ohnishi A; Sunden Y; Suzuki T; Tsuda M; Tanaka S; Sakai T; Nagashima K; Sawa H
J Cell Sci; 2006 Apr; 119(Pt 7):1433-41. PubMed ID: 16554441
[TBL] [Abstract][Full Text] [Related]
16. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
17. Id3 modulates cellular localization of bHLH Ptf1-p48 protein.
Dufresne M; Clerc P; Dieng M; Edir A; Couvelard A; Delisle MB; Fourmy D; Gigoux V
Int J Cancer; 2011 Jul; 129(2):295-306. PubMed ID: 20830706
[TBL] [Abstract][Full Text] [Related]
18. Id gene expression as a key mediator of tumor cell biology.
Israel MA; Hernandez MC; Florio M; Andres-Barquin PJ; Mantani A; Carter JH; Julin CM
Cancer Res; 1999 Apr; 59(7 Suppl):1726s-1730s. PubMed ID: 10197587
[TBL] [Abstract][Full Text] [Related]
19. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
[TBL] [Abstract][Full Text] [Related]
20. MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
Su Y; He Q; Deng L; Wang J; Liu Q; Wang D; Huang Q; Li G
Neuroreport; 2014 Jan; 25(1):12-7. PubMed ID: 24162743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
